Prostate cancer disease recurrence after radical prostatectomy is associated with <scp>HLA</scp> type and local cytomegalovirus immunity-Reference-Cited by-同舟云学术

Prostate cancer disease recurrence after radical prostatectomy is associated with HLA type and local cytomegalovirus immunity

Published:2022-08-31 Issue:19 Volume:16 Page:3452-3464
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Classon Johanna¹^ORCID,Zamboni Margherita¹,Engblom Camilla¹,Alkass Kanar²,Mantovani Giulia¹^ORCID,Pou Christian³,Nkulikiyimfura Dieudonné³,Brodin Petter³,Druid Henrik²,Mold Jeff¹,Frisén Jonas¹

Affiliation:

1. Department of Cell and Molecular Biology Karolinska Institutet Stockholm Sweden

2. Department of Pathology and Oncology Karolinska Institutet Stockholm Sweden

3. Science for Life Laboratory, Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden

Funder

Cancerfonden

Knut och Alice Wallenbergs Stiftelse

Stiftelsen för Strategisk Forskning

Vetenskapsrådet

Karolinska Institutet

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13273

Reference38 articles.

1. Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis

2. Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline

3. The inflammatory microenvironment and microbiome in prostate cancer development

4. HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer

5. Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Cytomegalovirus in Prostate Cancer Incidence and Mortality;European Urology Oncology;2024-02

2. Immune Cells and Metabolites in Prostate Cancer Pathogenesis: A Mendelian Randomization Analysis;2024

3. Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study;International Journal of Molecular Sciences;2023-10-20

4. The role of cytomegalovirus in prostate cancer incidence and mortality;2023-10-05

5. Cytomegalovirus promotes proliferation and survival of prostate cancer cells and constitutes a therapeutic target;2023-10-01